Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$111,346
+$61,590 QoQ
Shares Held
45,080
+214.4% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 3.3096716947648623.ToString("F0")%
Shared 15.967169476486246.ToString("F0")%
None 80.7231588287489.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cerity Partners LLC holds $355,640,511 across 116 Biotechnology names. EDIT ranks #86 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
296,654 | $132,467,876 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43,972 | $33,974,525 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
731,689 | $29,494,383 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
349,137 | $22,564,723 | |
| 5 | INCY |
Incyte Corp
|
226,501 | $21,318,272 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
263,389 | $14,878,843 | |
| 7 | EXEL |
Exelixis, Inc.
|
313,945 | $13,465,100 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
45,746 | $8,648,280 |
All Filings in EDIT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $111,346 | 45,080 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $49,756 | 14,339 | Shares | Other | 2025-10-22 | |
| 2025-06-30 | $33,070 | 15,032 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $56,909 | 49,060 | Shares | Sole | 2025-04-30 | |
| 2024-09-30 | $66,825 | 19,597 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||